Genes Tech Group Holdings Co Ltd (8257)

Hong Kong

Currency in HKD

0.241

-0.001(-0.41%)

Closed·02:59:59

Fair Value

Unlock Value

Day's Range

0.241

0.242

52 wk Range

0.050

0.242

8257 Income Statement

Featured here, the Income Statement (earnings report) for Genes Tech Group Holdings Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

Total Revenues

aa.aa

1,497.83

1,497.33

1,598.9

1,332.83

931.96

Total Revenues Growth

aa.aa

-21.51%

-0.03%

+6.78%

-16.64%

-30.08%

Cost Of Revenues

aa.aa

1,097.91

1,155.16

1,233.62

1,006.87

668.63

Gross Profit

aa.aa

399.92

342.17

365.28

325.96

263.33

Gross Profit Growth

aa.aa

-18.17%

-14.44%

+6.75%

-10.76%

-19.21%

Gross Profit Margin %

aa.aa

26.7%

22.85%

24.46%

28.26%

Other Operating Expenses, Total

aa.aa

202.1

211.8

191.42

177.89

180.43

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-2.07%	+4.8%	-9.62%	-7.07%	+1.43%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	202.1	211.8	191.42	186.54	177.59
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-8.65	2.84

Operating Income

aa.aa

197.82

130.38

173.86

148.07

82.91

Operating Income Growth

aa.aa

-29.93%

-34.09%

+33.35%

-14.83%

-44.01%

EBIT Margin %

aa.aa

13.21%

8.71%

10.87%

11.11%

8.9%

Net Interest Expenses

aa.aa

-14.25

-12.25

-14.35

-18.58

-17.52

Net Interest Expenses Growth

aa.aa

+2.09%

+14.02%

-17.13%

-29.5%

+5.69%

Interest Expense, Total

aa.aa

-14.38

-12.35

-14.79

-19.59

-18.67

Interest And Investment Income

aa.aa

0.14

0.1

0.44

1.01

1.15

Other Non Operating Expenses, Total

aa.aa

8.74

7.21

18.87

-3.21

26.87

EBT, Excl. Unusual Items

aa.aa

192.31

125.34

178.38

126.28

92.26

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

7.76

-257.79

EBT, Incl. Unusual Items

aa.aa

196.63

118.36

-82.38

126.28

92.26

EBT, Incl. Unusual Items Growth

aa.aa

-24.48%

-39.81%

-169.61%

+253.29%

-26.94%

EBT, Incl. Unusual Items Margin

aa.aa

13.13%

7.9%

-5.15%

9.47%

9.9%

Income Tax Expense

aa.aa

52.43

38.95

-1.95

35.64

67.98

Net Income to Company

aa.aa

144.2

79.4

-80.44

90.64

24.28

Minority Interest

aa.aa

Net Income

aa.aa

144.2

79.4

-80.44

90.64

24.28

Net Income Growth

aa.aa

-19.46%

-44.94%

-201.3%

+212.68%

-73.21%

Net Income Margin %

aa.aa

9.63%

5.3%

-5.03%

6.8%

2.61%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

144.2

79.4

-80.44

90.64

24.28

Basic EPS - Continuing Operations

aa.aa

0.14

0.08

-0.08

0.09

0.02

Basic EPS - Continuing Operations Growth

aa.aa

-19.46%

-44.94%

-201.3%

+212.68%

-73.21%

Diluted EPS - Continuing Operations

aa.aa

0.14

0.08

-0.08

0.09

0.02

Diluted EPS - Continuing Operations Growth

aa.aa

-19.46%

-44.94%

-201.3%

+212.68%

-73.21%

Basic Weighted Average Shares Outstanding

aa.aa

1,000

Diluted Weighted Average Shares Outstanding

aa.aa

1,000

Dividend Per Share

aa.aa

0.04

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

223.07

159.03

199.29

173.09

109.24

EBITDA Growth

aa.aa

-26.13%

-28.71%

+25.32%

-13.15%

-36.89%

EBITDA Margin %

aa.aa

14.89%

10.62%

12.46%

12.99%

11.72%

EBIT

aa.aa

197.82

130.38

173.86

148.07

82.91

* In Millions of TWD (except for per share items)

FAQ

What was Genes Tech’s revenue at year end?

At the end of the last reported fiscal year, Genes Tech (8257) recorded total revenue of 931.958.

How much revenue did Genes Tech report in the most recent quarter?

In its most recent quarterly earnings report, Genes Tech posted revenue of 585.31.

What was Genes Tech’s net income for the year?

For the full year, Genes Tech reported net income of 24.280.

How much net income did Genes Tech post in the last quarter?

In the most recent quarter, Genes Tech (8257) posted net income of 48.70.

What was Genes Tech’s gross profit for the year?

Gross profit for the year was reported at 263.333.

How much gross profit did Genes Tech generate last quarter?

Genes Tech recorded gross profit of 201.974 in its latest quarterly report.

What was Genes Tech’s annual operating income?

For the full year, Genes Tech (8257) reported operating income of 82.907.

What was Genes Tech’s operating income last quarter?

Quarterly operating income was 107.732.

What was Genes Tech’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 120.533.

What was the quarter-over-quarter change in EBITDA for Genes Tech?

EBITDA changed by 250.764% compared to the last quarter.

How did Genes Tech’s revenue change compared to the previous quarter?

Revenue changed by 47.450% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Genes Tech?

In the latest quarter 2026, gross profit changed by 89.208% from the previous quarter.

S&P/TSX

31,994.60

-576.95

-1.77%

S&P/TSX 60

1,860.57

-25.27

-1.34%

US 30

48,904.80

-3.6

-0.01%

US 500

6,794.80

-3.3

-0.05%

S&P 500 VIX

21.33

-0.44

-2.02%

DAX

24,465.63

+17.05

+0.07%

Dollar Index

97.735

+0.034

+0.03%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	69.14	+0.88%	15.03M
Bank of Nova Scotia	103.20	+1.08%	8.79M
Toronto Dominion Bank	130.17	-0.15%	7.18M
Bank of Montreal	191.60	-0.45%	3.90M
RBC	231.13	-0.53%	3.42M
National Bank of Canada	168.12	+0.72%	2.47M
Constellation Software	2,477.22	-0.23%	184.36K

Name	Last	Chg. %	Vol.
Grounded People Apparel	0.100	+1,900.00%	2.50K
PeakBirch Logic	0.030	+500.00%	1.32K
New Leaf Ventures	0.05	+400.00%	666.82K
TripSitter Clinic	0.49	+226.67%	600.00
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Yumy Bear Goods	0.02	+100.00%	1.00K

Name	Last	Chg. %	Vol.
Metamaterial	0.25	-92.86%	0.00
Intellabridge Technology Corp	0.02	-50.00%	10.00K
Premier Health of America	0.02	-50.00%	21.68K
Nuinsco Resources	0.0050	-50.00%	3.00K
Ampd Ventures	0.01	-50.00%	3.50K
Beckett’s	0.02	-50.00%	40.90K
Vice Health Wellness	0.005	-50.00%	2.22M

Trending Stocks

Name	Last	Chg. %	Vol.
BCE Inc	35.03	-2.56%	8.96M
Constellation Software	2,477.22	-0.23%	184.36K
Celestica Inc.	400.89	+6.48%	1.03M
TELUS	19.56	+0.31%	7.69M
Hut 8	60.870	-17.58%	1.66M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaa Aaaaaa	88.78	+64.16%	145.74
Aaaaaaaaa	31.22	+50.03%	46.84
Aaaaaaa Aaaaaaa	2.36	+49.64%	3.53
Aaaaaaaa	21.44	+49.03%	31.95
A Aaaaa Aaaaaa Aa	120.95	+48.21%	179.26
Aaaaaaaaaaaaaaaaaa	13.36	+48.08%	19.78
Aaa Aaaaaaaa Aaaa A	62.80	+46.35%	91.91

Name	Last	Upside	Fair Value
Aaaaa Aaaaaa	88.78	+64.16%	145.74
Aaaaaaaaa	31.22	+50.03%	46.84
Aaaaaaa Aaaaaaa	2.36	+49.64%	3.53
Aaaaaaaa	21.44	+49.03%	31.95
A Aaaaa Aaaaaa Aa	120.95	+48.21%	179.26
Aaaaaaaaaaaaaaaaaa	13.36	+48.08%	19.78
Aaa Aaaaaaaa Aaaa A	62.80	+46.35%	91.91

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Genes Tech Group Holdings Co Ltd (8257)

8257 Income Statement

FAQ

What was Genes Tech’s revenue at year end?

How much revenue did Genes Tech report in the most recent quarter?

What was Genes Tech’s net income for the year?

How much net income did Genes Tech post in the last quarter?

What was Genes Tech’s gross profit for the year?

How much gross profit did Genes Tech generate last quarter?

What was Genes Tech’s annual operating income?

What was Genes Tech’s operating income last quarter?

What was Genes Tech’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Genes Tech?

How did Genes Tech’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Genes Tech?

Trending Stocks